New hope for painful skin condition: drug trial seeks 210 volunteers
Disease control
Recruiting now
This study tests a new medicine called BFB759 for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. About 210 adults will receive either the drug or a placebo for up to 40 weeks to see if it reduces abscesses and inflamed bumps. The goal is t…
Phase: PHASE2, PHASE3 • Sponsor: Bluefin Biomedicine, Inc. • Aim: Disease control
Last updated May 26, 2026 12:08 UTC